Ladi ☆ Thailand, 2016-02-23 10:22 (3378 d 11:16 ago) Posting: # 16022 Views: 10,620 |
|
Dear forum members, I have questions regarding the calibration curve range considering the statement in "EMEA Guideline on bioanalytical method validation" that says "At least 2 QC sample levels should fall within the range of concentrations measured in study samples". My first question is whether this statement is considered acceptance criteria of each analytical run? Supposedly, we validated a calibration curve range of 10-100 ng/mL, and LQC is 30, MQC is 50 and HQC is 80 ng/mL. Now please let me set up two scenarios as following. Scenario 1--- After we analyzed our first batch of study samples, the Cmax are: subject 1 period 1 is 48 ng/mL period 2 is 35 ng/mL subject 2 period 1 is 52 ng/mL period 2 is 65 ng/mL subject 3 period 1 is 70 ng/mL period 2 is 30 ng/mL Questions: Since 2 QC levels do not fall within the range of drug concentrations measured from subject 1 (in both periods) and subject 3 (period 2), 1) Is this analytical run accepted? 2) Would you continue with the study or what would you do next? 3) If we continue the study with same curve and QC and the rest of data are somewhat in this trend, can authority reject this study? Scenario 2---After we analyzed our first batch of study samples, the Cmax are: subject 1 period 1 is 44 ng/mL period 2 is 48 ng/mL subject 2 period 1 is 47 ng/mL period 2 is 45 ng/mL subject 3 period 1 is 48 ng/mL period 2 is 49.5 ng/mL Similar questions: Since 2 QC levels do not fall within the range of drug concentrations measured from every subjects, 1) Is this analytical run accepted? 2) Would you continue with the study or what would you do next? 3) If we continue the study with same curve and QC and the rest of data are somewhat in this trend, can authority reject this study? I really appreciate your time in reading and answering my questions. So sorry for asking similar topic again in this forum but we still having this big issue. Thank you, Ladi (Thailand) Edit: Category changed. [Helmut] |
ritesh.korat.pharma ☆ India, 2016-02-26 20:35 (3375 d 01:04 ago) @ Ladi Posting: # 16032 Views: 8,723 |
|
Dear Ladi To satisfy EMEA guideline which states that minimum two QC covered within Cmax of that particular period you can take following steps Firstly monitor around 20% of first subject of the study. if Cmax of both periods of that subjects (at least 67% among them) will cross two QC than no need of additional QC and if its not cross than add one more QC between LQC and MQC. The all procedure must be incorporated in SOP prior to analysis E.g. if you have to perform analysis of 100 subjects then you can monitor first twenty subjects among them 20% of 100 subjects is 20 if Cmax of both period in 14 (67% of 20) subjects out of that 20 subjects cross two QC level than no need of additional QC and if its not than add one more QC between LQC and MQC. so, in remaining subjects cmax cross two QC levels Regards, Ritesh Korat |
Ladi ☆ Thailand, 2016-03-03 07:02 (3369 d 14:36 ago) @ ritesh.korat.pharma Posting: # 16043 Views: 8,504 |
|
Dear Ritesh, Thank you for your suggestion. I will take your suggestion to our team for further discussion. Regards, Ladi |
Ohlbe ★★★ France, 2016-03-03 17:46 (3369 d 03:52 ago) @ ritesh.korat.pharma Posting: # 16046 Views: 8,540 |
|
Dear Ritesh Korat, ❝ Firstly monitor around 20% of first subject of the study. Why wait till 20 %, if it is already visible after 2-3 runs that the concentrations are lower than expected ? ❝ if Cmax of both period in 14 (67% of 20) subjects out of that 20 subjects cross two QC level than no need of additional QC Why 67 % ? Where did you take that figure from ? IMHO what's important is not just how many subjects have a Cmax below the MQC sample - but also how much below it is. ❝ and if its not than add one more QC between LQC and MQC. Or adjust the concentration of the existing MQC. The guidelines also gives this option. — Regards Ohlbe |
Ohlbe ★★★ France, 2016-03-03 17:41 (3369 d 03:57 ago) @ Ladi Posting: # 16045 Views: 8,566 |
|
Dear Ladi, ❝ My first question is whether this statement is considered acceptance criteria of each analytical run? Clearly not:
❝ Supposedly, we validated a calibration curve range of 10-100 ng/mL, and LQC is 30, MQC is 50 and HQC is 80 ng/mL. Now please let me set up two scenarios as following. With just a 10-fold difference between the LLOQ and the ULOQ you're in trouble... ❝ 2) Would you continue with the study or what would you do next? I would stop and lower the LLOQ to be able to measure concentrations down to 5 % of Cmax... SCNR. I understand that you took this as a theoretical example. To answer your questions:
— Regards Ohlbe |
wienui ★ Germany/Oman, 2019-02-20 19:13 (2285 d 02:25 ago) @ Ohlbe Posting: # 19943 Views: 5,341 |
|
Dear all, In a BE study, the average Cmax of subjects samples was found out of the ULOQ of the calibration curve. Please enlighten me, is this acceptable? Best regards, Osama — Cheers, Osama |
Helmut ★★★ ![]() ![]() Vienna, Austria, 2019-02-20 19:19 (2285 d 02:19 ago) @ wienui Posting: # 19944 Views: 5,321 |
|
Salam Osama, ❝ In a BE study, the average Cmax of subjects samples was found out of the ULOQ of the calibration curve. You’ve gotta be kidding! ![]() — Dif-tor heh smusma 🖖🏼 Довге життя Україна! ![]() Helmut Schütz ![]() The quality of responses received is directly proportional to the quality of the question asked. 🚮 Science Quotes |
wienui ★ Germany/Oman, 2019-02-20 19:32 (2285 d 02:06 ago) (edited on 2019-02-21 05:30) @ Helmut Posting: # 19945 Views: 5,381 |
|
❝ Salam Osama, ❝ ❝ ❝ In a BE study, the average Cmax of subjects samples was found out of the ULOQ of the calibration curve. ❝ ❝ You’ve gotta be kidding! Salam Helmut, No, my friend, I hoped I were kidding but unfortunately this is the reality. Moreover, it was given as a justification that samples were reanalyzed after dilution with blank human plasma to bring the analyte concentration into the validated calibration curve range which then multiplied by the dilution factor and reported in the final table of concentrations and that only 5% of subjects'samples have concentrations above ULOQ ( although we speak about the average Cmax!!!) very nice!!!! regards, Osama — Cheers, Osama |